The Insider Activity Report For OPKO Health Inc. (OPK): Who’s Buying?

OPKO Health Inc. (NASDAQ:OPK) traded with an addition of $0.01 to $4.29 on Friday, an upside of 0.30 percent. An average of 3,738,080 shares of common stock have been traded in the last five days. There was a fall of -$0.15 in the past week, and it reached a new high 4 times over the past 12 months. The last 20 days have seen an average of 6,166,885 shares traded, while the 50-day average volume stands at 4,803,982.

OPK stock has increased by 12.63% in the last month. The company shares reached their 1-month lowest point of $3.74 on 12/15/21. With the stock rallying to its 52-week high on 01/03/22, shares of the company touched a low of $3.26 and a high of $6.27 in 52 weeks. It has reached a new high 1 time so far this year and lost -11.02% or -$0.51 in price. In spite of this, the price is down -31.53% from the 52-week high.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Valuation Metrics

OPKO Health Inc. (OPK) has a trailing price-to-earnings (P/E) ratio of 36.27, which compares with the 29.28 for the broader industry and 27.85 for the sector. The stock’s beta is 1.73. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.62, the price-to-book (PB) ratio at 1.58, and the price-to-cash flow ratio at 65.96.

The company has a payout ratio of 0.00%.

The quick ratio of OPKO Health Inc. for the three months ended September 29 was 1.60, and the current ratio was 2.00, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.11 and a total debt to equity ratio of 0.12 for the quarter ending September 29. OPKO Health Inc.’s EBITDA margin for the year ending September 29 is 9.69%, while its operating margin for the same period stands at 7.00%. Its gross profit as reported stood at $541.0 million compared to revenue of $1.44 billion.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, OPKO Health Inc.’s return on assets was 3.10%. For the broader industry, ROE averaged 3.60 over the past year.

Earnings Surprise

In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $28.74 million in the quarter, while revenues of -$16.19 million were grew 17.47%. The analyst consensus anticipated OPKO Health Inc.’s latest quarter earnings to come in at -$0.01 per share, but it turned out to be $0.04, a 500.00% surprise. For the quarter, EBITDA amounted to $56.97 million. Shareholders own equity worth $681.34 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at OPKO Health Inc. (OPK) price momentum. RSI 9-day as of the close on 13 January was 40.38%, suggesting the stock is Neutral, with historical volatility in this time frame at 47.29%.

As of today, OPK’s price is $4.45 -3.37% or -$0.15 from its 5-day moving average. OPK is currently trading +7.77% higher than its 20-day SMA and +13.76% higher than its 100-day SMA. However, the stock’s current price level is -2.93% below the SMA50 and -1.83% below the SMA200.

The stochastic %K and %D were 7.01% and 14.17%, respectively, and the average true range (ATR) was 0.23. With the 14-day stochastic at 9.52% and the average true range at 0.23, the RSI (14) stands at 45.60%. The stock has reached -0.16 on the 9-day MACD Oscillator while the 14-day reading was at -0.30.

Analyst Ratings

Ladenburg Thalmann launched coverage on OPKO Health Inc. (NASDAQ: OPK) in its analyst report released on June 21, 2021. The firm assigned the stock a a Buy rating. The consensus rating for OPKO Health Inc. (OPK) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell OPK, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 5 others rate it as a “buy”.

What is OPK’s price target for the next 12 months?

Analysts predict a range of price targets between $5.00 and $8.50, with a median target of $6.50. Taking a look at these predictions, the average price target given by analysts for OPKO Health Inc. (OPK) stock is $6.70.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_img

Hot Topics

Related Articles